Table of Contents Author Guidelines Submit a Manuscript
Journal of Veterinary Medicine
Volume 2015, Article ID 412501, 9 pages
http://dx.doi.org/10.1155/2015/412501
Research Article

An Antioxidant Dietary Supplement Improves Brain-Derived Neurotrophic Factor Levels in Serum of Aged Dogs: Preliminary Results

1Department of Veterinary Medicine, Pathology and Veterinary Clinic Section, Via Vienna 2, 07100 Sassari, Italy
2SANYpet S.p.a., Research and Development Department, Via Austria 3, Bagnoli di Sopra, 35023 Padua, Italy
3School of Specialization in Clinical Biochemistry, “G. d’Annunzio” University, Via dei Vestini 31, 66100 Chieti, Italy

Received 23 March 2015; Revised 1 June 2015; Accepted 7 June 2015

Academic Editor: Antonio Ortega-Pacheco

Copyright © 2015 Sara Sechi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Biological aging is characterized by a progressive accumulation of oxidative damage and decreased endogenous antioxidant defense mechanisms. The production of oxidants by normal metabolism damages proteins, lipids, and nucleotides, which may contribute to cognitive impairment. In this study 36 dogs were randomly divided into four groups and fed croquettes of different compositions for 6 months. We monitored derivatives of reactive oxygen metabolites (dROMs) and biological antioxidant potential (BAP) levels in dogs’ plasma samples as well as brain-derived neurotrophic factor (BDNF) serum levels at the beginning and at the end of the dietary regime. Our results showed that a dietary regime, enriched with antioxidants, induced a significant decrease of plasma levels of dROMs () and a significant increase in BDNF serum levels () after six months. Thus, we hypothesized a possible role of the diet in modulating pro- and antioxidant species as well as BDNF levels in plasma and serum, respectively. In conclusion the proposed diet enriched with antioxidants might be considered a valid alternative and a valuable strategy to counteract aging-related cognitive decline in elderly dogs.

1. Introduction

Biological aging is characterized by a progressive accumulation of oxidative damage and decreased endogenous antioxidant defense mechanisms [1]. The production of oxidants by normal metabolism damages proteins, lipids, and nucleotides which may contribute to neurodegeneration and, subsequently, cognitive impairment such as Alzheimer’s (AD) and Parkinson’s diseases (PD) [2, 3]. Although the body normally has sufficient protection producing endogenous antioxidants enzymes, such as catalase, glutathione and superoxide dismutase, an imbalance in the pro-oxidant/antioxidant species could increase the risk for lipid peroxidation DNA and protein damage. Oxidative damage also affects neuron function and may contribute to a cognition decline with age. The excess of reactive oxygen species in neuronal level can lead to irreversible damage of cytoskeleton and the microtubular network [4]. Microtubules, important dynamics polar formations of the cytoskeleton, are abundant in neurons, where they provide a scaffold also for their dendrites. Because of oxidative stress conditions the peroxynitrite may react with tyrosine to form 3-nitro-L-tyrosine (3NT). This final product may be selectively incorporated into the α-tubulin, resulting in an irreversible blocking of the characteristic dynamics of microtubules causing morphological changes, neuronal death and consequent onset of neurodegenerative diseases. Several experimental evidences have shown the importance of polyunsaturated fatty acids (PUFAs) in human and animal nutrition and development [5]. Further, an omega-3 and omega-6 deficiency likely correlates with the development of behavioral disorder [6].

Thus we hypothesized that a valid alternative and valuable strategy to counteract aging-related cognitive decline and neurodegeneration in aged dogs might be a dietary supplementation with antioxidants. Recent studies of animal models of neurodegenerative diseases suggest that dietary restriction can increase neurons endurance to age-related and disease-specific stresses [7]. Neurotrophic factors, including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), can protect neurons against death, as observed for in vivo and in vitro models of acute (stroke, trauma, and seizures) and chronic (Alzheimer’s and Parkinson’s diseases) neurodegenerative diseases [8].

Our interest in the neurological effects of age stems from a more general concern with the development of a canine model of human cognitive aging. Dogs show age-related pathology similar to that observed in elderly humans, like learning and development impairments [9]. Although the exact mechanisms have not been established so far, recent evidences indicate that a combination of an antioxidant-enriched diet with essential fatty acids, like omega-3 and omega-6, can be used to reduce age-dependent impairments and cognitive decline in aged dogs [10]. We focused on BDNF due to its role in supporting the survival and growth of many neuronal subtypes and in mediating the synaptic efficacy, neuronal connectivity and plasticity [11].

We hypothesized that BDNF serum levels might be modulated by an antioxidant-enriched diet.

In humans, BDNF mRNA and protein are decreased in the cortex and hippocampus in mild cognitive impairment (MCI) and AD [12] and are also decreased in cognitive decline [13]. In animals, decreased BDNF serum levels result in a LTP and memory deficit, thus increasing BDNF availability in the brain may be a viable strategy to counteract cognitive decline with aging.

The canine model provides us with an opportunity to test the relationship between cognitive impairment in aging, related to a decrease in BDNF serum levels, and the effects of non-pharmacological interventions.

The aim of this study was to evaluate the effects of a novel dietary supplement endowed with antioxidant properties as an adjuvant in the prevention of oxidative stress conditions and neurodegenerative disorders in aged dogs. The supplement consisted in a mixed formula of fished or chicken proteins, rice carbohydrates, Grifola frondosa, Curcuma longa, Carica papaya, Punica granatum, Aloe vera, Polygonum cuspidatum, Solanum lycopersicum, Vitis vinifera, Rosmarinus officinalis and an Omega 3/6 ratio of 1 : 0.8.

Grifola Frondosa is a culinary-medicinal mushroom that may play an important role in the prevention of many age-associated neurological dysfunctions, including Alzheimer’s and Parkinson’s diseases. The mushroom shows neuroprotective, antioxidant and anti-(neuro)inflammatory effects; in fact it reduces beta amyloid-induced neurotoxicity, neurite outgrowth stimulation, and nerve growth factor (NGF) synthesis [14]. It can be considered a useful therapeutic agent in the management and/or treatment of neurodegenerative diseases [15]. It was suggested that there could be an overall improvement in cognitive abilities of subjects when incorporated in their daily diet [16].

Curcuma Longa is a naturally occurring phytochemical compound endowed with powerful free radical scavenging activity [17]. Farinacci et al. observed that curcumin, polyphenol derived from Curcuma longa, reduced neutrophils adhesion and superoxide production in vitro [18]. Moreover, it resulted beneficially in improving spatial attention and motivation deficits associated with impaired cognition in aging and AD, in both humans and dogs [19]. Head et al. observed that 9 aged beagles provided with a medical food cocktail containing 95% of curcuminoids for 3 months had significantly lower error scores and were more accurate across all distances, suggesting an overall improvement in spatial attention [20]. da Rocha et al. demonstrated that C. longa had neuroprotective effects in vitro and in vivo by targeting biochemical pathways associated with neurodegenerative disorders that include cognitive impairments, energy/fatigue, mood and anxiety [21, 22].

Carica papaya is a natural compound with a high phenolic and flavonoid content which explains its free radical scavenging and antioxidant potential [2224]. Mehdipour et al. demonstrated its antioxidant effect in vitro and reported a significant decrease in blood lipid peroxidation, while the blood total antioxidant power resulted significantly increased () [24].

Punica granatum is a plant containing some species of flavonoids and anthocyanins, for example, delphinidin, cyaniding and pelargonidin, which have been shown to have an antioxidant activity in vitro [25] and in vivo [26]. The antioxidant action of P. granatum is related to its free radical scavenging activity against superoxide ions, mainly due to the presence of anthocyanins and to the ability to form metal chelates [25]. Rehydration effects have been also reported [27].

Aloe vera and its extracts have medicinal properties attributed to the active components such as anthrone, chromone, aloe verasin and hydroxylation [28, 29]. Sahu et al. demonstrated that Aloe vera had different degrees of antioxidant activity [30]. The antioxidant properties of this plant may depend on the radical scavenging activity. Moreover, life-long dietary supplementation of A. vera was shown to suppress many age-related consequences in vivo. Due to the presence of phenolic acids, polyphenols, sterols, fatty acids and indoles, A. vera may result to be effective in relieving symptoms associated with or preventing neurodegeneration [31].

Polygonum cuspidatum is an important natural source of resveratrol [32]. Due to its numerous pharmacological activities it has been used as an antioxidant [33]. Antioxidant activities of P. cuspidatum have been reported both in vivo and in vitro study [34]. Moreover, three of its dimers, parthenocissin A, quadrangularing A and pallidol, have shown strong free radical quenching and selective singlet oxygen scavenging activity [35]. Trans-resveratrol has been used as antidepressant in chronically stressed rats, probably by acting on the monoaminergic systems, such as the serotonergic and noradrenergic [33]. In fact, chronic treatment with trans-resveratrol was found to inhibit monoamine oxidase-A (MAO-A) activity in all the four brain regions, particularly in the frontal cortex and hippocampus [36].

Solanum lycopersicum is rich of vitamins C and E, lycopene, beta-carotene, lutein and flavonoids such as quercetin, phenols, ascorbic acid (AsA) and dehydroascorbic acid (DHA). It is considered an important plant able to prevent chronic diseases and improve energy balance and antioxidant activity [37]. Both direct and indirect antioxidant activity, as indicated by reduced malondialdehyde (MDA) and nitric oxide (NO) production and increased glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity, support the conclusion that tomatoes containing anthocyanins can potentially provide better protection against oxidative stress related chronic diseases [38].

Vitis vinifera can be considered as a potential source of natural antioxidants, due to the presence of carotenoids such as lutein, beta-carotene and polyphenols [39]. The antioxidant activity of grape extracts is due to their reducing power [40]. The grape seed flavanol/procyanidin compounds may act as similar as reductones by donating electrons and reaching with free radicals to convert them to more stable products and terminating the free radical chain reaction [40]. Antioxidant activities of V. vinifera were also assessed by their capacity to prevent Fe2+-induced lipid peroxidation in microsomes and their action on Cu2+-induced lipid peroxidation in low-density lipoproteins [41]. Astringin, a stilbenoid present in V. vinifera, is endowed with an important antioxidant effect and a higher radical scavenger activity [41].

Rosmarinus officinalis is known to exert an antiproliferative, antioxidant and antibacterial activity [42]. The crude extract also has shown antioxidant and anti-inflammatory activities inhibiting NO production and reducing proinflammatory cytokines (IL-1β) and enzymes (COX-2) mRNA expression in LPS-activated cells thus highlighting its chemopreventive potential [43]. Afonso et al. showed that phenolic compounds from R. officinalis protected against hypercholesterolemia-induced oxidative stress, increasing the activities of antioxidant enzymes [44]. Several literature reports have demonstrated that R. officinalis exerted multiple benefits for neuronal system and alleviated mood disorders [45]. In particular its active compounds, luteolin, carnosic acid and rosmarinic acid, exhibited neurotrophic effects by improving cholinergic functions [46] and showed neuroprotective properties by inhibiting amyloid precursor protein synthesis and higher brain-derived neurotrophic factor production in hypothalamus cells [45]. Antidepressant-like effect of R. officinalis may be mediated by an interaction with the dopaminergic system, through the activation of dopamine D1 and D2 receptors [47].

Omega 3/6 fatty acids: a good balance of the Omega 3/6 fatty acids ratio in the food is a basic requirement to improve the inflammatory and neurological background [48]. More in detail, n-3 polyunsaturated fatty acids, usually found in fish oil, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to both decrease the production of proinflammatory mediators and inhibit natural killer cell activity [49]. Moreover preclinical studies suggested that low plasma omega-6 and omega-3 fatty acids levels were associated with accelerated decline of peripheral nerve function with aging [50]. Intake of PUFAs, mainly omega-3 and omega-6, was shown to increase BDNF production in brain [50, 51]. Docking studies on PUFAs and their metabolites with BDNF revealed that PUFAs metabolites, mainly LXA_4, NPD1 and HDHA, had more binding affinity towards BDNF [51]. These metabolites of PUFAs are also responsible for modulation of BDNF activity [51].

2. Methods

2.1. Subjects

Thirty-six dogs of different breeds were randomly and equally divided into four groups based on age and diet (Table 1). First group, made up of 8 dogs (three males and five females, age , mean ± standard error of the mean), was fed a control diet with organic chicken. Second group, made up of 8 dogs (three males and five females, age , mean ± standard error of the mean), was fed a chicken-based food enriched with natural antioxidants. The third group, made up of 8 dogs (four males and four females, age , mean ± standard error of the mean), was fed a fish-based meal and the fourth one was made up of 8 dogs (three males and five females, age , mean ± standard error of the mean) and was fed a fished-based meal enriched with natural antioxidants.

Table 1: Dogs’ diet groups and their features.

d-ROMs and BAP tests (Free Radical Analytical System FRAS 4, H&D s.r.l., Langhirano PR, Italy) were performed before (T0) and at the end (T1) of the treatment in all animals in order to determine the oxidative stress status. The four diets were administered for a six-month period.

2.2. Sample Collection and Analysis

Blood samples were collected from each dog before the new dietary regime (T0) and at the end of the treatment (T1) after six months from cephalic vein and stored in two tubes, one with heparin and the other without anticoagulant. Heparinized plasma samples and serum samples were obtained by blood centrifugation at 4000 g× 1,5 min at 37°C.

The derivatives of reactive oxygen metabolites (dROMs) and the biological antioxidant potential (BAP), as indicators of oxidative stress, were measured by portable spectrophotometer (Free Radical Analytical System FRAS 4, H&D s.r.l., Langhirano PR, Italy) on plasma samples. In the dROMs test, reactive oxygen metabolites (primarily hydroperoxides) of the sample, in presence of iron released from plasma proteins by an acidic buffer, generate alkoxyl and peroxyl radicals, according to the Fenton reaction. Such radicals then oxidize an alkyl-substituted aromatic amine (N,N-dietylparaphenylendiamine), thus producing a pink-colored derivative which is photometrically quantified at 505 nm [52]. The dROMs concentration is directly proportional to the colour intensity and is expressed as U.CARR (Carratelli Units). One U.CARR corresponds to 0.8 mg/L hydrogen peroxide. The reference values of dROMS are summarized below:(i)reference value 50–90 U.CARR;(ii)threshold borderline: 92–95 U.CARR;(iii)condition of mild oxidative stress: 100–120 U.CARR;(iv)condition of oxidative stress: 140–200 U.CARR;(v)condition of strong oxidative stress: 220–300 U.CARR;(vi)strong oxidative stress: over 300 U.CARR.

In the BAP test plasma samples were added with a colored solution, obtained by mixing a ferric chloride solution with a thiocyanate derivative solution, which causes a discoloration, whose intensity is measured photometrically at 505 nm and it is proportional to the ability of the plasma to reduce ferric ions. The results are expressed as μMol/L of reduced ferric ions. Both tests were validated for canine species [53]. Range values of BAP are listed below:(i)reference value 2000–4000 μMol/L;(ii)optimal values: >2200 μMol/L;(iii)threshold borderline: 2200–2000 μMol/L;(iv)discrete deficiency state: 2000–1800 μMol/L;(v)deficiency state: 1800–1600 μMol/L;(vi)strong deficiency state: 1600–1400 μMol/L;(vii)very strong deficiency state: <1400 μMol/L.

2.3. BDNF Analysis

BDNF analysis was performed with BG BDNF ELISA kit (Blue Gene Biotech CO., LTD, Shanghai, China) designed for the quantitative determination of canine BDNF. The ELISA test reaction was performed using Crocodile mini Workstation (Totertek Berthold, Pforzheim, Germany). The kit utilizes a monoclonal anti-BDNF antibody and BDNF-HRP conjugate. The assay sample and buffer are incubated together with BDNF-HRP conjugate in precoated plate for one hour. After the incubation period, the wells are washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450 nm with a microplate reader. The intensity of the color is inversely proportional to the BDNF concentration since BDNF from samples and BDNF-HRP conjugate compete for the anti-BDNF antibody binding site. Since the number of sites is limited, as more sites are occupied by BDNF from the sample, fewer sites are led to bind BDNF-HRP conjugate. A standard curve is then plotted relating the intensity of the color (O.D) to the concentration of standards. The BDNF concentration of each sample is interpolated from this standard curve.

2.4. Statistical Analysis

All data are presented as the mean ± SEM. An unpaired 2-sample Student’s -test was used to compare the differences in plasma dROMs, BAP, and BDNF levels between the four groups. All statistical analyses were performed with GraphPad Prism 6 (GraphPad Software Inc., San Diego, CA, USA). was considered significant.

3. Results

3.1. Oxidative Stress Status Evaluation

We firstly analyzed dROMs and BAP levels as a measure of the oxidative stress status of dogs. Analysis was made on dogs plasma in all of the four groups before starting the new dietary regime (T0) and at the end, after six months (T1).

As shown in Figure 1, a significant decrease in plasma levels of dROMs, after six months of feeding regime, in groups 2 and 4 (food supplemented with antioxidant) was observed (). dROMs levels remained unaltered in the first (control group) and third groups (fish-based meal, without antioxidant addition).

Figure 1: Graphical representation of dROMs in plasma of aged dogs before and after the 6 months of the dietary regime. A significant decrease of dROMs levels was observed in dogs fed with antioxidant supplementation, in the second group () and in the fourth group (), respectively.

These data indicate that a diet enriched with natural antioxidant might be able to promote a decrease of reactive species in plasma of aged dogs.

Antioxidant influence, evaluated with BAP analysis, remained unchanged in all groups of dogs after the diet (Figure 2).

Figure 2: Graphical representation of BAP in plasma of aged dogs before and after 6 months of the dietary regime. BAP levels did not show significant modifications in all groups of dogs after the diet.

Natural antioxidants seemed to modulate the balance between pro- and antioxidant species through the decrease of dROMs without increasing natural antioxidant defense.

3.2. BDNF Evaluation

Literature reports have shown a decrease in BDNF serum levels to negatively correlate with cognitive decline and deficits in LTP and memory in dogs [13]. BDNF is a neurotrophic factor that can protect neurons against death supporting the survival and growth of many neuronal subtypes [8]. An increase in BDNF serum levels is one of the factors underlying improvements in learning and memory [8, 54]. Increasing BDNF availability in the brain, by diet, may be a viable strategy to counteract cognitive decline with aging [7, 55, 56].

We reported a significant BDNF serum levels increase in groups of dogs that received a diet enriched with antioxidant, (Figure 3), while in the other groups BDNF serum levels remain unchanged.

Figure 3: Graphical representation of BDNF in plasma of aged dogs before and after the 6 months of the dietary regime. A significant increase of BDNF levels was observed in dogs fed with antioxidant supplementation, in the second group () and in the fourth group (), respectively.

4. Discussion

The purpose of this study was to evaluate the possible potential ability of a long-term dietary antioxidant supplementation in controlling the oxidative stress and the general health status of aged dogs. Moreover we demonstrated a possible modulation of BDNF serum levels by a diet with antioxidant supplementation.

Environmental stress and aging may induce psychological stress that possibly influences also the nutrition of pets. An unbalanced diet deficient in essential nutrients may represent a risk factor of degenerative diseases. Among the several mechanisms by which nutrients influence the health status, the balance of oxidative stress has a relevant role. Constantly, in the animal species, metabolic oxidative reactions take place. The goal of these reactions is to balance free radicals production with antioxidants molecules.

The inhibitory activity of antioxidant molecules was observed in in vitro studies using plants derivative compounds such as flavonoids, anthocyanins and other poliphenols evaluating their effects on the converting activities of α-amylase, α-glucosidase and angiotensin-converting enzyme (ACE). They all have shown an inhibitory activity on α-amylase, α-glucosidase and ACE [57].

Furthermore, a significant reduction in dROMs values in the experimental diet enriched with natural antioxidants was observed. In apparently healthy dogs, serum levels of the dROMs ranged between 50 and 90 U.CARR. These values were in agreement with those reported by Pasquini et al. [53]. The antioxidant supplementation significantly decreased dROMs levels from 155 U.CARR (T0) to 120 U.CARR (T1) in the second group and from 150 U.CARR (T0) to 95 U.CARR (T1) in the forth group. Differently, dogs fed the control diet, deficient in antioxidant nutrients, did not modulate the oxidative stress status. The antioxidant status revealed by BAP test was not affected by nutrition and values were at optimal levels throughout the observational period. Probably antioxidant supplements only affected dROMs species but not the endogenous antioxidant components of dogs, which remained in the initial optimal condition. This might be related to the really efficacy of the experimental diet in modulating the oxidative stress.

The antioxidant formulation employed in this experiment was based on Grifola frondosa, Curcuma longa, Carica papaya, Punica granatum, Aloe vera, Polygonum cuspidatum, Solanum lycopersicum, Vitis vinifera and Rosmarinus officinalis extracts.

All these compounds contain anthocyanins and polyphenols with antioxidant effects [7].

With this study we showed a decrease in dROMs species following the administration of the analyzed antioxidant formulation.

Our study reporting the scavenger activity of an antioxidant supplementation in dogs diet is in agreement with other studies about antioxidant effects of singular active principles included into an antioxidant supplementation [58]. The anthocyanins and polyphenols have antioxidant effects in some pathological conditions, such as metabolic disorders, aging-related diseases, cardiovascular diseases cancer, and inflammatory-related disturbs, as well as carotenoids and flavonoids [39, 59]. These compounds are inhibitors of lipid peroxidation probably by interfering with the glutathione activity [60].

Resveratrol (3,5,4′-trihydroxystilbene) is a polyphenol naturally present in grapes, berries, peanuts, and other vegetables [61], with therapeutic and neuroprotective functions [7]. Moreover trans-resveratrol, which is highly presented in Polygonum cuspidatum, could modulate BDNF levels through the monoaminergic system activation [36]. In our study we observed that a diet enriched with natural antioxidants was able to increase BDNF serum levels from  pg/mL to  pg/mL, while in the other groups remained unchanged. As to Grifola frondosa, an improvement in cognitive abilities in aged dogs was observed when adding Curcuma longa and Aloe vera to a daily diet through a stimulation of the BDNF synthesis [16]. According to what was observed by Sasaki et al., luteolin, carnosic acid, and rosmarinic acid, from Rosmarinus officinalis, exerted a neuroprotective activity probably modulating the neurotrophic metabolic pathway in the neuronal system [46]. Finally, Kumar et al. observed that PUFAs, like omega-3 and omega-6, along with their metabolites, had more binding affinity towards BDNF [51]. Further, the serum level increase of both fatty acids might be modulated by these metabolites which in turn could regulate the BDNF production in the brain. Neurotrophic factors, such as BDNF, can protect neurons against death and be a preventive approach in neurodegenerative conditions [7, 8].

By means of this new canine model of aging, we showed that providing antioxidants within a specific dietary supplement it was possible to restore the balance between pro- and antioxidants species, possibly modulating also BDNF serum levels. Future studies in both aged humans and dogs will be more effective if antioxidants combinations will be evaluated along with additional lifestyle improvements such as cognitive training and physical exercise.

Conflict of Interests

None of the authors has any financial or personal relationship that could inappropriately influence or bias the content of the paper.

Acknowledgment

This paper was supported in part by grants from Regional Law 7 August 2007 n°7, “Promozione della Ricerca scientifica e dell’innovazione tecnologica in Sardegna”.

References

  1. T. M. Hagen, D. L. Yowe, J. C. Bartholomew et al., “Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3064–3069, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Tavakkoli, R. Miri, A. R. Jassbi et al., “Carthamus, Salvia and Stachys species protect neuronal cells against oxidative stress-induced apoptosis,” Pharmaceutical Biology, vol. 52, no. 12, pp. 1550–1557, 2014. View at Publisher · View at Google Scholar
  3. X. L. Wang, G. H. Xing, B. Hong et al., “Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway,” Life Sciences, vol. 114, no. 2, pp. 77–85, 2014. View at Publisher · View at Google Scholar
  4. K. Fukui, A. Masuda, A. Hosono et al., “Changes in microtubule-related proteins and autophagy in long-term vitamin E-deficient mice,” Free Radical Research, vol. 48, no. 6, pp. 649–658, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Molteni, R. J. Barnard, Z. Ying, C. K. Roberts, and F. Gómez-Pinilla, “A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning,” Neuroscience, vol. 112, no. 4, pp. 803–814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Murphy, G. P. Dias, and S. Thuret, “Effects of diet on brain plasticity in animal and human studies: mind the gap,” Neural Plasticity, vol. 2014, Article ID 563160, 32 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Duan, J. Lee, Z. Guo, and M. P. Mattson, “Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury,” Journal of Molecular Neuroscience, vol. 16, no. 1, pp. 1–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. P. Mattson, S. Maudsley, and B. Martin, “BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders,” Trends in Neurosciences, vol. 27, no. 10, pp. 589–594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. S. Dowling and E. Head, “Antioxidants in the canine model of human aging,” Biochimica et Biophysica Acta, vol. 1822, no. 5, pp. 685–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Kearns, M. G. Hayek, J. J. Turek et al., “Effect of age, breed and dietary omega-6 (n-6): omega-3 (n-3) fatty acid ratio on immune function, eicosanoid production, and lipid peroxidation in young and aged dogs,” Veterinary Immunology and Immunopathology, vol. 69, no. 2–4, pp. 165–183, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. D. K. Binder and H. E. Scharfman, “Brain-derived neurotrophic factor,” Growth Factors, vol. 22, no. 3, pp. 123–131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Michalski and M. Fahnestock, “Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease,” Molecular Brain Research, vol. 111, no. 1-2, pp. 148–154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Peng, J. Wuu, E. J. Mufson, and M. Fahnestock, “Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease,” Journal of Neurochemistry, vol. 93, no. 6, pp. 1412–1421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ling-Sing Seow, M. Naidu, P. David, K.-H. Wong, and V. Sabaratnam, “Potentiation of neuritogenic activity of medicinal mushrooms in rat pheochromocytoma cells,” BMC Complementary and Alternative Medicine, vol. 13, article 157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-W. Phan, P. David, M. Naidu, K.-H. Wong, and V. Sabaratnam, “Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism,” Critical Reviews in Biotechnology, 2014. View at Publisher · View at Google Scholar
  16. V. Sabaratnam, W. Kah-Hui, M. Naidu, and P. David, “Neuronal health—can culinary and medicinal mushrooms help?” Journal of Traditional and Complementary Medicine, vol. 3, no. 1, pp. 62–68, 2013. View at Google Scholar · View at Scopus
  17. S. Prasad, S. C. Gupta, A. K. Tyagi, and B. B. Aggarwal, “Curcumin, a component of golden spice: from bedside to bench and back,” Biotechnology Advances, vol. 32, no. 6, pp. 1053–1064, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Farinacci, M. Colitti, and B. Stefanon, “Modulation of ovine neutrophil function and apoptosis by standardized extracts of Echinacea angustifolia, Butea frondosa and Curcuma longa,” Veterinary Immunology and Immunopathology, vol. 128, no. 4, pp. 366–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Chin, P. Huebbe, K. Pallauf, and G. Rimbach, “Neuroprotective properties of curcumin in Alzheimer's Disease—merits and limitations,” Current Medicinal Chemistry, vol. 20, no. 32, pp. 3955–3985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Head, H. L. Murphey, A. L. S. Dowling et al., “A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 32, no. 4, pp. 1029–1042, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. da Rocha, F. P. dias Viegas, H. C. Campos et al., “The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II. Alzheimer's disease,” CNS and Neurological Disorders—Drug Targets, vol. 10, no. 2, pp. 251–270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Srikanth, S. Manohar Babu, C. H. N. Kavitha, M. E. Bhanoji Rao, N. Vyaykumar, and C. H. Pradeep, “Studies on in-vitro antioxidant activities of Carica papaya aqueous leaf extract,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 1, no. 2, pp. 59–65, 2010. View at Google Scholar · View at Scopus
  23. K. Imao, H. Wang, M. Komatsu, and M. Hiramatsu, “Free radical scavenging activity of fermented papaya preparation and its effect on lipid peroxide level and superoxide dismutase activity in iron-induced epileptic foci of rats,” Biochemistry and Molecular Biology International, vol. 45, no. 1, pp. 11–23, 1998. View at Google Scholar · View at Scopus
  24. S. Mehdipour, N. Yasa, G. Dehghan et al., “Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to α-tocopherol,” Phytotherapy Research, vol. 20, no. 7, pp. 591–594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. N. P. Seeram, R. N. Schulman, and D. Heber, Pomegranates: Ancient Roots to Modern Medicine, Taylor & Francis, Boca Raton, Fla, USA, 2006.
  26. K. N. Chidambara Murthy, G. K. Jayaprakasha, and R. P. Singh, “Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models,” Journal of Agricultural and Food Chemistry, vol. 50, no. 17, pp. 4791–4795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. P. C. Pande, L. Tiwari, and H. C. Pande, “Ethnoveterinary plants of Uttaranchal—a review,” Indian Journal of Traditional Knowledge, vol. 6, no. 3, pp. 444–458, 2007. View at Google Scholar
  28. M. D. Boudreau and F. A. Beland, “An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera,” Journal of Environmental Science and Health—Part C Environmental Carcinogenesis and Ecotoxicology Reviews, vol. 24, no. 1, pp. 103–154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Eshun and Q. He, “Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries—a review,” Critical Reviews in Food Science and Nutrition, vol. 44, no. 2, pp. 91–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. P. K. Sahu, D. D. Giri, R. Singh et al., “Therapeutic and medicinal uses of Aloe vera: a review,” Pharmacology & Pharmacy, vol. 4, no. 8, pp. 599–610, 2013. View at Publisher · View at Google Scholar
  31. F. Nejatzadeh-Barandozi, “Antibacterial activities and antioxidant capacity of Aloe vera,” Organic and Medicinal Chemistry Letters, vol. 3, article 5, 2013. View at Publisher · View at Google Scholar
  32. L. Chen, Y. Han, F. Yang, and T. Zhang, “High-speed counter-current chromatography separation and purification of resveratrol and piceid from Polygonum cuspidatum,” Journal of Chromatography A, vol. 907, no. 1-2, pp. 343–346, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Xu, Z. Wang, W. You et al., “Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system,” European Neuropsychopharmacology, vol. 20, no. 6, pp. 405–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Q. R. Sheela and V. A. Raman, “In-vitro antioxidant activity of Polygonium barbatum Leaf extract,” Asian Journal of Pharmaceutical and Clinical Research, vol. 4, supplement 1, 2011. View at Google Scholar
  35. I. Gülçin, “Antioxidant properties of resveratrol: a structure-activity insight,” Innovative Food Science and Emerging Technologies, vol. 11, no. 1, pp. 210–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Yu, R. Wang, C. Chen et al., “Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences,” Journal of Psychiatric Research, vol. 47, no. 3, pp. 315–322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Dorais, D. L. Ehret, and A. P. Papadopoulos, “Tomato (Solanum lycopersicum) health components: from the seed to the consumer,” Phytochemistry Reviews, vol. 7, no. 2, pp. 231–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Li, Z. Deng, R. Liu, S. Loewen, and R. Tsao, “Bioaccessibility, in vitro antioxidant activities and in vivo anti-inflammatory activities of a purple tomato (Solanum lycopersicum L.),” Food Chemistry, vol. 159, pp. 353–360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-I. Bunea, N. Pop, A. C. Babeş, C. Matea, F. V. Dulf, and A. Bunea, “Carotenoids, total polyphenols and antioxidant activity of grapes (Vitis vinifera) cultivated in organic and conventional systems,” Chemistry Central Journal, vol. 6, article 66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. G. K. Jayaprakasha, R. P. Singh, and K. K. Sakariah, “Antioxidant activity of grape seed (Vitis vinifera) extracts on peroxidation models in vitro,” Food Chemistry, vol. 73, no. 3, pp. 285–290, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Fauconneau, P. Waffo-Teguo, F. Huguet, L. Barrier, A. Decendit, and J.-M. Merillon, “Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests,” Life Sciences, vol. 61, no. 21, pp. 2103–2110, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. A. I. Hussain, F. Anwar, S. A. Shahid Chatha, A. Jabbar, S. Mahboob, and P. Singh Nigam, “Rosmarinus officinalis essential oil: antiproliferative, antioxidant and antibacterial activities,” Brazilian Journal of Microbiology, vol. 41, no. 4, pp. 1070–1078, 2010. View at Publisher · View at Google Scholar
  43. S. Cheung and J. Tai, “Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis,” Oncology Reports, vol. 17, no. 6, pp. 1525–1531, 2007. View at Google Scholar · View at Scopus
  44. M. S. Afonso, A. M. de O Silva, E. B. Carvalho et al., “Phenolic compounds from Rosemary (Rosmarinus officinalis L.) attenuate oxidative stress and reduce blood cholesterol concentrations in diet-induced hypercholesterolemic rats,” Nutrition and Metabolism, vol. 10, article 19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Ramachandran, K.-W. Quirin, E. Escalon, and S. J. Melnick, “Improved neuroprotective effects by combining Bacopa monnieri and Rosmarinus officinalis supercritical CO2 extracts,” Journal of Evidence-Based Complementary and Alternative Medicine, vol. 19, no. 2, pp. 119–127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Sasaki, A. El Omri, S. Kondo, J. Han, and H. Isoda, “Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation,” Behavioural Brain Research, vol. 238, no. 1, pp. 86–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. D. G. MacHado, V. B. Neis, G. O. Balen et al., “Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: evidence for the involvement of the dopaminergic system,” Pharmacology Biochemistry and Behavior, vol. 103, no. 2, pp. 204–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. A. P. Simopoulos, “The importance of the ratio of omega-6/omega-3 essential fatty acids,” Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 365–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Verlengia, R. Gorjão, C. C. Kanunfre et al., “Effects of EPA and DHA on proliferation, cytokine production, and gene expression in Raji cells,” Lipids, vol. 39, no. 9, pp. 857–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Lauretani, S. Bandinelli, B. Bartali et al., “Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons,” European Journal of Neurology, vol. 14, no. 7, pp. 801–808, 2007. View at Publisher · View at Google Scholar
  51. Y. P. Kumar, G. S. Srinivas, Y. Mitravinda E, L. Malla, and A. A. Rao, “Agonistic approach of omega-3, omega-6 and its metabolites with BDNF: an In-silico study,” Bioinformation, vol. 9, no. 18, pp. 908–911, 2013. View at Publisher · View at Google Scholar
  52. A. Pasquini, E. Luchetti, V. Marchetti, G. Cardini, and E. L. Iorio, “Analytical performances of d-ROMs test and BAP test in canine plasma. Definition of the normal range in healthy Labrador dogs,” Veterinary Research Communications, vol. 32, no. 2, pp. 137–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Pasquini, E. Luchetti, and G. Cardini, “Evaluation of oxidative stress in hunting dogs during exercise,” Research in Veterinary Science, vol. 89, no. 1, pp. 120–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. M. F. Egan, M. Kojima, J. H. Callicott et al., “The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function,” Cell, vol. 112, no. 2, pp. 257–269, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Wu, Z. Ying, and F. Gomez-Pinilla, “Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats,” Journal of Neurotrauma, vol. 21, no. 10, pp. 1457–1467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Duan, J. Lee, Z. Guo, and M. P. Mattson, “Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury,” Journal of Molecular Neuroscience, vol. 16, no. 1, pp. 1–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Oboh, A. O. Ademosun, A. O. Ademiluyi, O. S. Omojokun, E. E. Nwanna, and K. O. Longe, “In vitro studies on the antioxidant property and inhibition of α-amylase, α-glucosidase, and angiotensin I-converting enzyme by polyphenol-rich extracts from cocoa (Theobroma cacao) bean,” Pathology Research International, vol. 2014, Article ID 549287, 6 pages, 2014. View at Publisher · View at Google Scholar
  58. D. K. Gessner, A. Fiesel, E. Most et al., “Supplementation of a grape seed and grape marc meal extract decreases activities of the oxidative stress-responsive transcription factors NF-kappaB and Nrf2 in the duodenal mucosa of pigs,” Acta Veterinaria Scandinavica, vol. 55, article 18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Ø. Moskaug, H. Carlsen, M. C. W. Myhrstad, and R. Blomhoff, “Polyphenols and glutathione synthesis regulation,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 277S–283S, 2005. View at Google Scholar · View at Scopus
  61. W. Yu, Y.-C. Fu, and W. Wang, “Cellular and molecular effects of resveratrol in health and disease,” Journal of Cellular Biochemistry, vol. 113, no. 3, pp. 752–759, 2012. View at Publisher · View at Google Scholar · View at Scopus